Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Nebius Group Aktie: Verzögerungen beim Ausbau der Rechenzentrumskapazitäten belasten kurzfristige... (Aktiencheck) +++ NEBIUS Aktie +3,56%

AMD Aktie

 >AMD Aktienkurs 
471.8 EUR    -2.5%    (TradegateBSX)
Ask: 471.4 EUR / 400 Stück
Bid: 471.05 EUR / 400 Stück
Tagesumsatz: 26790 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
AMD Aktie über LYNX handeln
>AMD Performance
1 Woche: +20,6%
1 Monat: -10,6%
3 Monate: +15,5%
6 Monate: +27,2%
1 Jahr: +127,2%
laufendes Jahr: +163,0%
>AMD Aktie
Name:  ADVANCED MICRO DEVICES (AMD)
Land:  USA
ISIN/ Wkn:  US0079031078 / 863186
Symbol/ Ticker:  AMD (Frankfurt) / AMD (NASDAQ)
Kürzel:  FRA:AMD, ETR:AMD, AMD:GR, NASDAQ:AMD
Index:  S&P500, Nasdaq100
Webseite:  https://www.amd.com/
Profil:  Advanced Micro Devices Inc. is a global semiconductor company focused on high-performance and adaptive computing. The company develops processors, graphics technologies, and specialized accelerators used across data center, client, gaming, and embedd..
>Volltext..
Marktkapitalisierung:  794680.7 Mio. EUR
Unternehmenswert:  788607.59 Mio. EUR
Umsatz:  41222.63 Mio. EUR
EBITDA:  10067.95 Mio. EUR
Nettogewinn:  6912.48 Mio. EUR
Gewinn je Aktie:  4.23 EUR
Schulden:  8089.2 Mio. EUR
Liquide Mittel:  6623.06 Mio. EUR
Operativer Cashflow:  8277.01 Mio. EUR
Bargeldquote:  1.09
Umsatzwachstum:  46.95%
Gewinnwachstum:  138.72%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 13.087.787 Euro.
Suchwörter:  AMD, ADVANCED MICRO
Letzte Datenerhebung:  16.11.26
>AMD Kennzahlen
Aktien/ Unternehmen:
Aktien: 1640.09 Mio. St.
Frei handelbar: 99.49%
Rückkaufquote: -0.01%
Mitarbeiter: 31000
Umsatz/Mitarb.: 1.01 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 23.36%
Bewertung:
KGV: 119.35
KGV lG: 66.41
KUV: 21.27
KBV: 13.17
PEG-Ratio: 0.99
EV/EBITDA: 78.33
Rentabilität:
Bruttomarge: 51.19%
Gewinnmarge: 17%
Operative Marge: 17.72%
Managementeffizenz:
Gesamtkaprendite: 9%
Eigenkaprendite: 11.96%
 >AMD Anleihen 
>AMD Peer Group
Elektronik / Software, KI- Anwendungen, -Software & -Infrastruktur, Halbleiterhersteller & Zulieferer/ Chip- Entwicklung, Unterhaltungs-, Haushalts- & Computerelektronik, Festplatten-, Arbeitsspeicher- & Prozessoren- Hersteller
 
16.11.26 - 15:48
Take-Two isn′t the only stock with a stake in GTA 6 (The Street)
 
GTA 6 launches Nov. 19. Sony, AMD and Best Buy all have a stake in Take-Two's biggest release, but their paydays differ in size and timing....
16.11.26 - 15:45
AMD completes acquisition of AI startup World Labs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.11.26 - 15:42
Graid Technology Inc.: Graid Technology Extends VROC to AMD EPYC Platforms, Expanding Choice in Enterprise RAID (Accesswire)
 
CPU-based NVMe RAID arrives on AMD EPYC platforms in February 2027, with no dedicated RAID controller required SUNNYVALE, CA / ACCESS Newswire / November 16, 2026 / Graid Technology today announced......
16.11.26 - 15:24
4D Molecular Therapeutics forciert Gentherapie bei feuchter AMD: Phase-III-Ergebnisse für 2027 im Visier (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.11.26 - 15:12
NVIDIA Falls 4% Ahead of Earnings as Elon Musk Joins Calls to Reinstate Jensen Huang; AMD Drops 6%, Taiwan Semiconductor Slides 5% (24/7 Wall St.)
 
Wall Street is pricing a leadership shock and a looming earnings test into NVIDIA (NASDAQ:NVDA) all at once. NVIDIA stock is at $157.01, down 4% in morning trading. The decline compounds a slide that has left the stock down 29% over the past month. Stock futures are lower, with NVIDIA leading AI stocks down. Earnings […]...
16.11.26 - 15:06
AMD Completes Acquisition of World Labs (GlobeNewswire EN)
 
News Highlights ...
16.11.26 - 14:18
Ollin Biosciences and Its Next-Generation Medicines for Patients with Vision-Threatening Eye Diseases to be Acquired (Business Wire)
 
Lead program OLN324 is a next-generation, Phase 3 investigational, VEGF/Ang2 bispecific antibody being developed for diabetic macular edema and wet age-related macular degenerationAUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (“Ollin”), a privately-held clinical-stage biopharmaceutical company developing therapies for serious eye diseases, today announced it has entered into a definitive agreement to be acquired by Johnson & Johnson for $2.2 billion upfront with the potential for up to approximately $1.1 billion in additional regulatory and commercial milestone payments. Ollin was founded in 2023 with a mission to identify and accelerate the development of next-generation therapies in ophthalmology. Ollin's lead program is OLN324, a Phase 3 investigational bispecific antibody designed to target VEGF and Ang2 with optimized molecular size and potency. OLN324 is being developed for wet AMD and diabetic macular edema, two serious retinal diseases affecting more than 40 million people worldwide...
16.11.26 - 14:06
Johnson & Johnson to acquire Ollin Biosciences and late-stage bispecific antibody with best-in-class potential in ophthalmology (Business Wire)
 
Acquisition adds OLN324, a Phase 3 investigational bispecific antibody for retinal vascular diseases, including wet AMD and diabetic macular edema Accelerates Company's ambition to preserve, restore and enhance vision Builds on Johnson & Johnson's long-standing presence as an innovator in vision NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced it has entered into a definitive agreement to acquire Ollin Biosciences, Inc., (“Ollin”) a clinical-stage biopharmaceutical company developing therapies for serious eye diseases, for $2.2 billion upfront, with the potential for additional regulatory and commercial milestone payments. Johnson & Johnson will also enter into a separate development funding agreement with Blackstone Life Sciences (“Blackstone”) to support the Phase 3 clinical advancement of OLN324, contingent upon acquisition close. With this agreement, Johnson & Johnson would add to its pipeline OLN324, an investigational bispecific antibody designed to targe...
16.11.26 - 12:12
AMD Earnings: What Wall Street Missed (Fool)
 
AMD's latest earnings reveal a striking disconnect between business performance and investor expectations. See what's driving the sell-off and what could change the stock's direction....
16.11.26 - 11:24
Advanced Micro Devices vs. Broadcom: One Stock Has a $27 Billion Advantage Investors Shouldn′t Ignore (Fool)
 
Both semiconductor giants are benefiting from accelerating AI infrastructure investment, but substantial differences in profitability, cash generation, and valuation could shape their returns....
16.11.26 - 07:01
AMD statt Nvidia: Analyst sieht neuen Sieger im Chipmarkt (Wallstreet-Online)
 
Nach dem Rücktritt von Nvidia-CEO Jensen Huang stuft William Blair AMD hoch. Analysten sehen große Chancen auf zusätzliche Marktanteile....
15.11.26 - 18:18
AMD vs. Broadcom: With NVDA’s Jensen Huang Gone, Which AI Stock Wins the Most? (24/7 Wall St.)
 
Which AI chip stock belongs in a retirement-focused portfolio right now—AMD (NASDAQ:AMD) or Broadcom (NASDAQ:AVGO)—with Jensen Huang out at NVIDIA (NASDAQ:NVDA)? Huang resigned on November 12, 2026 after reports of personal misconduct and a board investigation, and CFO Colette Kress became interim CEO. AMD and Broadcom stock got a boost from Nvidia's loss, then both […]...
15.11.26 - 18:12
Forget Jensen Huang’s Resignation. AMD May Be Nvidia’s Biggest Threat in 2027 (24/7 Wall St.)
 
Advanced Micro Devices (NASDAQ:AMD) has had a breakout 2026. Shares are up 149.37% year to date and closed at $534.06. The rally followed a quarter in which Data Center revenue rose 97% to $8.546B. Wall Street reconsidered the AI trade without Jensen Huang at NVIDIA (NASDAQ:NVDA), but AMD's larger opportunity is building beneath that story. […]...
15.11.26 - 14:36
The Evidence Is Piling Up: AMD Could Be the Best Artificial Intelligence (AI) Stock to Buy Amid the Sell-Off (Fool)
 
AMD seems poised to become a long-term winner due to its accelerating growth and a huge addressable market....
15.11.26 - 11:24
Anthropic Just Delivered Great News for AMD Investors and Bad News for Nvidia (Fool)
 
Anthropic just undermined one of Nvidia's chief competitive advantages....
15.11.26 - 01:36
Michael Burry sees 2 chip winners in Nvidia′s shake-up (The Street)
 
Michael Burry doubled his Nasdaq 100 puts after Jensen Huang left Nvidia. His pick of SMH over SOXX shows why he sees AMD and Broadcom as potential winners....
14.11.26 - 22:36
Nvidia Fell While AMD and Broadcom Jumped. Here′s What History Says Happens Next to All 3 Stocks. (Fool)
 
The news that led Jensen Huang to step down as CEO of Nvidia has crushed the company's stock price....
14.11.26 - 16:48
Why Analysts Think AMD Could Emerge as the Biggest Winner From Nvidia's Turmoil (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
14.11.26 - 16:42
AMD Just Crushed Nvidia by 32 Points After Scandal. Here’s How NVDA Can Come Back (24/7 Wall St.)
 
AMD (NASDAQ:AMD) or NVIDIA (NASDAQ:NVDA): after one of the most lopsided weeks in the competition between these two chipmakers, how do they compare for investors building a retirement portfolio? The Kobeissi Letter called AMD's run its greatest five-session outperformance against Nvidia since Nvidia's 1999 IPO. On verified closing prices for the week ended November 13, […]...
14.11.26 - 16:12
AMD Just Beat Nvidia by the Widest Margin Since 1999 (24/7 Wall St.)
 
One chipmaker posted record results and landed marquee cloud customers. Its biggest rival lost its CEO and stumbled again. The week produced a split no one has seen in 27 years, and the aftermath may be messier than the headline suggests....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Geschmack hängt nicht an unseren Bedürfnissen. Der Mann muß schon sehr gesittet sein, wenn er eine Frau nach Geschmack wählen soll. - Immanuel Kant
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!